Rolf Spirig

Hypoxia-Inducible Factor (HIF) as a Pharmacological Target for Prevention and Treatment of Infectious Diseases

PRDX2 and PRDX4 are negative regulators of hypoxia-inducible factors under conditions of prolonged hypoxia

Direct Type I IFN but Not MDA5/TLR3 Activation of Dendritic Cells Is Required for Maturation and Metabolic Shift to Glycolysis after Poly IC Stimulation

Metabolic reprogramming in macrophages and dendritic cells in innate immunity

Cellular pathophysiology of ischemic acute kidney injury

The pathogenesis of cardiac fibrosis

High-density lipoprotein phospholipids interfere with dendritic cell Th1 functional maturation

Inflammaging: a new immune–metabolic viewpoint for age-related diseases

A Novel Role of Endothelin-1 in Linking Toll-like Receptor 7-mediated Inflammation to Fibrosis in Congenital Heart Block

Inflammation and tumor progression: signaling pathways and targeted intervention

A novel, complement-mediated way to enhance the interplay between macrophages, dendritic cells and T lymphocytes

Myasthenia gravis

Efficacy and patient satisfaction in the use of subcutaneous immunoglobulin immunotherapy for the treatment of auto-immune neuromuscular diseases

Dendritic cell metabolism

Peroxiredoxin 1 Stimulates Endothelial Cell Expression of VEGF via TLR4 Dependent Activation of HIF-1α

The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment

Immunometabolism governs dendritic cell and macrophage function

Antimicrobial Resistance in ESKAPE Pathogens

The Complement Inhibitor Low Molecular Weight Dextran Sulfate Prevents TLR4-Induced Phenotypic and Functional Maturation of Human Dendritic Cells

IVIG in autoimmune disease — Potential next generation biologics

TLR2 and TLR4 agonists induce production of the vasoactive peptide endothelin-1 by human dendritic cells

Effects of TLR Agonists on the Hypoxia-Regulated Transcription Factor HIF-1α and Dendritic Cell Maturation under Normoxic Conditions